In this model, loss of ENPP1 in the tumor inhibited metastasis and restored immune infiltration and sensitivity to treatment with immune checkpoint inhibitors, which required cGAS in the tumor cells and STING in the host cells. Here, ENPP1 is linked to neoplasm.